Rubén Francés

Prof. Rubén Francés

Departamento Medicina Clínica, Universidad Miguel Hernández, 03550 San Juan de Alicante, Spain
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2021 in Nature Reviews Gastroenterology & Hepatology
Verified
Journal Article
Closed access
PDF file
Jordi Gracia-SanchoJordi Gracia-Sancho
Jordi Gracia-Sancho
ECEsther Caparrós
Esther Caparrós
AFAnabel Fernández-Iglesias
Anabel Fernández-Iglesias
RFRubén Francés
Rubén Francés

OJOriol Juanola
Oriol Juanola
SMSebastián Martínez
Sebastián Martínez
RFRubén Francés
Rubén Francés
IGIsabel Gomez-Hurtado
Isabel Gomez-Hurtado
Non-alcoholic fatty liver disease (NAFLD) is one of the most frequent causes of chronic liver disease in the Western world, probably due to the growing prevalence of obesity, metabolic diseases, and exposure to some environmental agents. In certain patients, simple hepatic steatosis can progress to non-alcoholic steatohepatitis (NASH), which can sometimes lead to liver cirrhosis and its complications including hepatocellular carcinoma. Understanding the mechanisms that cause the progression of NAFLD to NASH is crucial to be able to control the advancement of the disease. The main hypothesis considers that it is due to multiple factors that act together on genetically predisposed subjects to suffer from NAFLD including insulin resistance, nutritional factors, gut microbiota, and genetic and epigenetic factors. In this article, we will discuss the epidemiology of NAFLD, and we overview several topics that influence the development of the disease from simple steatosis to liver cirrhosis and its possible complications.

1 December 2019 in Journal of Hepatology
Verified
Journal Article
Closed access
MSMarcel Sorribas
Marcel Sorribas
MJManuel O. Jakob
Manuel O. Jakob
BYBahtiyar Yilmaz
Bahtiyar Yilmaz
HLHai Li
Hai Li
DSDavid Stutz
David Stutz
RWReiner Wiest
Reiner Wiest

4 November 2012 in Liver International
Verified
Journal Article
Closed access
PBPablo Bellot
Pablo Bellot
RFRubén Francés
Rubén Francés
JSJose Such
Jose Such

20 August 2010 in Hepatology
Verified
Journal Article
Open access
PDF file
PBPablo Bellot
Pablo Bellot
JGJuan Carlos García-Pagán
Juan Carlos García-Pagán
RFRubén Francés
Rubén Francés
JAJuan G. Abraldes
Juan G. Abraldes
MNMiguel Navasa
Miguel Navasa
JBJaime Bosch
Jaime Bosch
Presence of bacterial DNA in noninfected patients with cirrhosis and ascites is associated with a marked inflammatory response including activation of the inducible form of nitric oxide synthase and release of nitric oxide, similar to that observed in patients with sponta-neous bacterial peritonitis. Although presence of bacterial DNA is associated with an impaired prognosis, no information is available regarding its hemodynamic consequences. Systemic and hepatic hemodynamics before and after a liquid test meal were assessed in a series of 75 noninfected patients with cirrhosis (55 with ascites). Bacterial DNA was meas-ured by polymerase chain reaction. Bacterial DNA was detected only in patients with asci-tes. Clinical data and liver function were similar in ascitic patients with presence (n 5 21) or absence of bacterial DNA (n 5 34). Bacterial-DNA(1) patients had significantly lower mean arterial pressure ( P 5 0.002) and systemic vascular resistance ( P 5 0.03) than bacte-rial-DNA(2) patients. Cardiac output, cardiopulmonary pressures, hepatic venous pres-sure gradient (HVPG), and hepatic blood flow were similar in both groups. Thirty minutes after the test meal, in response to increased blood flow caused by postprandial hy-peremia, there was a significantly greater increase in HVPG and impaired hepatic vasore-laxation in bacterial-DNA(1) as compared with bacterial-DNA(2) patients, which indicates hepatic endothelial dysfunction. Indeed, the increase in HVPG after the test meal significantly correlated with serum bacterial DNA concentration. Conclusion: Pres-ence of bacterial DNA, a marker of bacterial translocation, is associated with aggravation of peripheral vasodilation and with worsening of intrahepatic endothelial dysfunction. (HEPATOLOGY 2010;52:2044-2052)

1 January 2020 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
JAJavier Ampuero
Javier Ampuero
RPRaluca Pais
Raluca Pais
RFRocío Aller de la Fuente
Rocío Aller de la Fuente
RGRocio Gallego-Duran
Rocio Gallego-Duran
JCJavier Crespo
Javier Crespo
EMElvira del Pozo Maroto
Elvira del Pozo Maroto